Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays ; volume:7 ; number:1 ; day:11 ; month:10 ; year:2023 ; pages:1-14 ; date:12.2023
npj precision oncology ; 7, Heft 1 (11.10.2023), 1-14, 12.2023
- Urheber
-
Wang, Danyi
Elenbaas, Brian
Murugesan, Karthikeyan
Shah, Kunal
Montesion, Meagan
Gounaris, Ioannis
Scheuenpflug, Juergen
Locatelli, Giuseppe
Feng, Zheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-023-00442-4
- URN
-
urn:nbn:de:101:1-2024020613205913992239
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Danyi
- Elenbaas, Brian
- Murugesan, Karthikeyan
- Shah, Kunal
- Montesion, Meagan
- Gounaris, Ioannis
- Scheuenpflug, Juergen
- Locatelli, Giuseppe
- Feng, Zheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
Prevalence of clinically actionable disease variants in exceptionally long-lived families
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Priority index for critical Covid-19 identifies clinically actionable targets and drugs
Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participants
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Clinically relevant discrepancies between different rheumatoid factor assays
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes
Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
Prevalence of clinically actionable disease variants in exceptionally long-lived families
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Priority index for critical Covid-19 identifies clinically actionable targets and drugs
Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participants
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Clinically relevant discrepancies between different rheumatoid factor assays
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes
Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
Prevalence of clinically actionable disease variants in exceptionally long-lived families
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Priority index for critical Covid-19 identifies clinically actionable targets and drugs
Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participants
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Clinically relevant discrepancies between different rheumatoid factor assays
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes